Clinical Trial Update: Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating neoadjuvant high-dose-rate brachytherapy before radical prostatectomy in men with prostate cancer; the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Prostate Cancer (Adenocarcinoma) | Phase 1, Phase 2 | Status: RECRUITING